ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3

Shangting Han , Jiayu Guo , Chenyang Kong , Jun Li , Fangyou Lin , Jiefu Zhu , Tianyu Wang , Qi Chen , Yiting Liu , Haochong Hu , Tao Qiu , Fan Cheng , Jiangqiao Zhou

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (9) : e70024

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (9) : e70024 DOI: 10.1002/ctm2.70024
RESEARCH ARTICLE

ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3

Author information +
History +
PDF

Abstract

•Ankyrin repeat domain 1 (ANKRD1) is rapidly activated in renal ischaemia‒reperfusion injury (IRI) models in vivo and in vitro.

•ANKRD1 knockdown mitigates kidney damage and preserves renal function.

•Ferroptosis contributes to the deteriorating function of ANKRD1 in renal IRI.

•ANKRD1 promotes acyl-coenzyme A synthetase long-chain family member 3 (ACSL3) degradation via the ubiquitin‒proteasome pathway.

•The E3 ligase tripartite motif containing 25 (TRIM25) is responsible for ANKRD1-mediated ubiquitination of ACSL3.

Keywords

ACSL3 / ANKRD1 / ferroptosis / renal ischaemic‒reperfusion injury / TRIM25 / ubiquitination

Cite this article

Download citation ▾
Shangting Han, Jiayu Guo, Chenyang Kong, Jun Li, Fangyou Lin, Jiefu Zhu, Tianyu Wang, Qi Chen, Yiting Liu, Haochong Hu, Tao Qiu, Fan Cheng, Jiangqiao Zhou. ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3. Clinical and Translational Medicine, 2024, 14(9): e70024 DOI:10.1002/ctm2.70024

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

94

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/